Four Things to Know About the Infant Formula Shortage Right Now

Tips from a clinical dietitian for keeping babies healthy when formula is in short supply. It’s no secret the COVID pandemic has brought with it a spate of supply chain challenges. The latest product in crisis: infant and child formula.The shortage has affected nearly all types of formulas, hitting those who require special formulas the hardest: children with milk allergies, developmental disabilities and special needs, among other conditions.

Henry Ford Cardiologist to Perform a Live Heart Procedure at International Medical Education Event

DETROIT (May 17, 2022) – For the third straight year, Henry Ford Hospital interventional cardiologist Khaldoon Alaswad, M.D. will perform a  live heart procedure as part of an international interactive medical education event, with proceeds benefiting hospitals in Ukraine.Dr. Alaswad, director of the cardiac catheterization lab, will perform an advanced heart procedure known as chronic total occlusion percutaneous coronary intervention, as part of CTO LIVE AID 2022, a livestreamed event to provide invaluable training to cardiologists around the world.

COVID-19, MIS-C and Kawasaki Disease Share Same Immune Response

COVID-19, MIS-C and KD all share a similar underlying mechanism involving the over-activation of particular inflammatory pathways, UC San Diego study shows. Findings support novel drug targets for MIS-C.

Late-Breaking Science Announced for TVT 2022

The Cardiovascular Research Foundation (CRF) announced that TVT: The Structural Heart Summit will feature 12 studies as Late-Breaking Clinical Science and Featured Clinical Research. An annual meeting covering cutting-edge research and techniques for structural heart interventions, TVT will take place June 8-10, 2022, at the Sheraton Grand Chicago Riverwalk in Chicago, Illinois.

New Report Published Comparing Hemodynamics of Cardiac Shock in COVID-19 Patients in Pandemic’s First Vs. Second Wave

A new report by a team of cardiologists from the Heart & Vascular Hospital, Hackensack Meridian Hackensack University Medical Center that compares the hemodynamics of cardiac shock in patients with COVID-19 during the first versus the second wave of the COVID-19 pandemic was published recently in JACC: Journal of the American College of Cardiology.

TVT 2022 Program Now Available

The program for TVT 2022: The Structural Heart Summit is now available online. An annual meeting from the Cardiovascular Research Foundation (CRF), TVT features cutting-edge research and techniques for structural heart interventions and will take place June 8-10, 2022 at the Sheraton Grand Chicago Riverwalk in Chicago, Illinois.

Targeting Molecular Pathway that Causes Pulmonary Arterial Hypertension

UC San Diego researchers describe the underlying signaling pathway that results in pulmonary arterial hypertension and a novel monoclonal antibody therapy that blocks the abnormal blood vessel formation characterizing the disease.

Cleveland Clinic-Led Trial Finds That Experimental ‘Gene Silencing’ Therapy Reduces Lipoprotein(a), an Important Risk Factor of Heart Disease, By Up To 98%

Findings from a new Cleveland Clinic-led phase 1 trial show that an experimental “gene silencing” therapy reduced blood levels of lipoprotein(a), a key driver of heart disease risk, by up to 98%.

Findings from the “APOLLO Trial: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial” were presented today during a late-breaking science session at American College of Cardiology’s 71st Annual Scientific Session and simultaneously published online in the Journal of the American Medical Association.

Trial Compares Two Devices Used For Percutaneous Left Atrial Appendage Closure

SWISS-APERO is the first randomized clinical trial comparing Amulet with the new generation Watchman FLX device in terms of residual left atrial appendage (LAA) patency after percutaneous LAA closure (LAAC) as evaluated by 45-day cardiac computed tomography angiography (CCTA). The study showed that the two devices achieve a similar rate of LAA occlusion at 45 days but through different mechanism. Furthermore, Amulet as compared with Watchman FLX was associated with higher procedural complications but similar clinical outcomes at 45-days.

Randomized Study Examines Outcomes of Plug-based and Suture-based Vascular Closure Following TAVR Procedures

Results from the largest randomized trial available comparing different closure device strategies following transcatheter aortic valve replacement (TAVR) found that a plug-based vascular closure technique had a shorter time to hemostasis but a higher rate of access-site or access-related vascular complications.

Transcatheter Aortic Valve Replacement is Cost Effective Compared With Surgical Replacement for Low-Risk Patients

An economic analysis of data from PARTNER 3, a randomized trial comparing transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in patients with severe aortic stenosis and low surgical risk, found that despite higher procedural costs, at 2-year follow-up, quality-adjusted life expectancy was greater and total costs were lower with TAVR; as a result, at 2-years, TAVR was cost-effective for these patients.

Patients With Diabetes Undergoing PCI Have Less Target Lesion Failure With Amphilimus-eluting Stents

Results from SUGAR, a randomized, controlled, multicenter trial conducted exclusively in patients with diabetes mellitus (DM) and with minimum exclusion criteria, found that amphilimus-eluting stents (AES) were superior to zotarolimus-eluting stents (ZES) with regard to target lesion and target vessel failure composite outcomes at one year.

Study Finds That PCI Guided by FFR Did Not Meet Noninferiority for One-Year Outcomes Compared to Bypass Surgery

The primary results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 trial found that percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) did not meet noninferiority for one-year adverse events compared to coronary artery bypass grafting (CABG) in patients with three-vessel coronary artery disease. Patients with a low SYNTAX score (which measures the complexity of coronary artery disease) had less incidence of adverse events compared to those with intermediate or high SYNTAX scores, and in this cohort of patients PCI performed more favorably.

Study Examines Combined Effects of Medical Titration and Renal Denervation Treatment–Resistant Hypertension

Six-month outcomes from the randomized RADIANCE-HTN TRIO Trial comparing endovascular ultrasound renal denervation (RDN) to a sham procedure for treatment-resistant hypertension (HTN) found that the addition of a pharmacologic intervention led to further blood pressure reductions after RDN with a smaller increase in additional medications prescribed and less use of diuretics.

Intermediate-Risk Patients Have Similar Five-Year Outcomes With Transcatheter Or Surgical Aortic Valve Replacement

New five-year data from the SURTAVI trial found that there was no difference in all-cause mortality or stroke between patients at intermediate surgical risk who had transcatheter aortic valve replacement (TAVR) or surgery. Although there were initially more reinterventions after TAVR, the rates were similar after two years and key clinical endpoints were also similar.

New Treatment Approach for Advanced Coronary Artery Disease Leads to Improved Outcomes

Study outlines better way to identify where stents are necessary

New study reveals heart patients “orphaned” following aortic dissection repair despite ongoing risk of complications and death

A new study from the Peter Munk Cardiac Centre reveals that patients who survive an aortic dissection often fail to receive comprehensive post-surgical follow-up care leaving them vulnerable to a lifetime of sustained risk.

CRF Announces Free Online Access to TCT 2021

The Cardiovascular Research Foundation (CRF) is pleased to announce that the digital component of TCT 2021 will now be free for the entire interventional community. After careful consideration and achieving a critical level of support, CRF’s leadership has agreed to fully support this initiative. Complimentary online registration will include access to all content via livestream during the meeting and on-demand access for one year.

Shrinking Waveforms on Electrocardiograms Predict Worsening Health and Death of Hospitalized COVID-19 and Influenza Patients

Spotting changes in the heart’s electrical activity may prompt more-aggressive treatment and monitoring.

Heart rhythm disorders: Mayo Clinic Healthcare expert shares 5 things it’s important to know

World Heart Day is Sept. 29 – Heart rhythm disorders are one of the most common cardiac problems. Arrhythmias cause the heart to beat too fast, too slow, or irregularly. People can be born with them or develop them during their lives.

Study Shows Use of Smartphone App Associated with Lower Hospital Readmission Rates for Heart Attack Survivors

Data collected from a group of 200 heart attack survivors using a smartphone app designed to navigate the recovery process, such as medication management and lifestyle changes, showed that app users experienced hospital readmission within the first 30 days of discharge at half the rate of a comparable group given standard aftercare without the app.

CRF Announces TCT 2021 Late-Breaking Trials and Science

The Cardiovascular Research Foundation (CRF) has announced 22 late-breaking trial and science presentations that will be reported at TCT 2021. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. It will take place November 4-6, 2021 in Orlando, Florida at the Orange County Convention Center and simultaneously broadcast live.

UT Southwestern Among Top 25 in Nation in Eight Specialties Ranked By U.S. News ‘Best Hospitals’

UT Southwesternonce again is ranked the No. 1 hospital in Dallas-Fort Worth – the nation’s fourth-largest metro area – among 132 regional hospitals and second in Texas among 566 hospitals for the fifth consecutive year. The recognition comes several months after UT Southwestern completed expansion of its William P. Clements Jr. University Hospital.

MedStar Washington Hospital Center Again Named Among Nation’s Best Hospitals for Heart Care

MedStar Washington Hospital Center has been named among the nation’s top heart hospitals by U.S. News and World Report. Its Cardiology and Heart Surgery program climbed to #30, up seven from last year’s “Best Hospitals” rankings. It is the only nationally recognized heart program of its kind in the Washington region.

Rush University Medical Center Again on U.S. News & World Report Honor Roll

Of the more than 3,000 U.S. hospitals evaluated, Rush University Medical Center ranked No. 19 in the nation by U.S. News & World Report, with nine of specialties rated among the country’s very best.

Bidirectional impact of cardiovascular disease, cancer in Blacks focus of new AHA center

Cardiovascular disease and cancer, the nation’s top two killers, share common ground like obesity and chronic inflammation, as well as a disproportionate impact on Black Americans. A new American Heart Association-funded center at the Medical College of Georgia is working…